News

PET
progress.org.uk > scotland-introduces-newborn-screening-for-spinal-muscular-atrophy

Scotland introduces newborn screening for spinal muscular atrophy | PET

12+ hour, 13+ min ago  (452+ words) The Scottish Government has launched newborn screening for spinal muscular atrophy (SMA), allowing earlier diagnosis and access to potentially life-changing treatment. SMA is a rare genetic condition causing progressive muscle weakness, affecting breathing, swallowing and movement. Detecting SMA before symptoms…...

PET
progress.org.uk > tv-review-zembla-what-are-the-consequences-of-the-global-trade-in-donor-sperm

TV Review: Zembla – What are the consequences of the global trade in donor sperm? | PET

13+ hour, 18+ min ago  (225+ words) Legal experts featured in the programme argue that the current situation may constitute a violation of children's human rights, and that the Dutch state has an obligation to intervene. The Donor Child Foundation is now preparing to take that argument…...

PET
progress.org.uk > radio-review-womans-hour-going-it-alone

Radio Review: Woman's Hour – Going it alone | PET

2+ week, 11+ hour ago  (219+ words) The strength in the programme lies in its simplicity: real women explaining how they reached their decisions and what day-to-day life looks like now. There is no dramatic framing or attempt to push a narrative. Instead, it highlights a family…...

PET
progress.org.uk > first-uk-birth-following-womb-transplant-from-dead-donor

First UK birth following womb transplant from dead donor | PET

4+ week, 12+ hour ago  (381+ words) A boy named Hugo has become the first child in the UK to be born following a womb transplant from a dead donor. His birth in December 2025 comes ten months after the UK's first baby born from a womb donation…...

Progress Educational Trust
progress.org.uk > nhs-delivers-genome-editing-treatment-for-beta-thalassaemia

NHS delivers genome-editing treatment for beta thalassaemia

2+ mon, 3+ week ago  (169+ words) A woman with transfusion-dependent beta thalassaemia has become one of the first patients in southern England to receive the genome-editing therapy Casgevy through the NHS. Treated at University College London Hospital, she underwent the one-off procedure in November 2025 after requiring…...